Search is Powered by Google
Cancer / Oncology News

Stanford Co-Sponsors November 8th Conference To Discuss Life After Cancer Treatment

Main Category: Cancer / Oncology
Article Date: 06 Nov 2008 - 9:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 stars

4 (2 votes)

Health Professional:4 stars

4 (1 votes)

Article Opinions: 0 posts

The Northern California Cancer Center, the Stanford Cancer Center and the American Cancer Society are co-sponsoring Nov. 8 the second annual Cancer Survivorship Conference "Now what? The new normal of cancer survivorship after treatment."

The conference is intended to help cancer survivors and their families, support networks and health care professionals understand and navigate questions and issues that arise after treatment ends, from a patient's physical and psychosocial needs to advocacy and family concerns.

Speakers ranging from cancer survivors to representatives from the region's leading medical institutions will discuss transitioning from an oncologist to primary care doctor, genetics and family risk, management of side effects of cancer treatment, psychosocial issues, intimacy and sexuality, integrative medicine, nutrition and lifestyle, caregiver/family communication, estate and financial planning, health and life insurance and employment.

The event is free to the public. It will be held from 8 a.m. to 3:30 p.m. at the Mission Bay Conference Center at the University of California-San Francisco, 1675 Owens St., San Francisco. For more information or to register, please visit http://www.nccc.org, e-mail the NCCC at education@nccc.org or call (888) 315-5988.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu.

Stanford University Medical Center




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...